Eli Lilly and Boehringer Ingelheim's blockbuster diabetes drug Jardiance (empagliflozin) has been granted approval by the US Food and Drug Administration (FDA) for a wider range of heart failure ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback